Member Info for sightwatcher

Fugazi1: you are a entertainer and you enjoy the IAG SP decline for some reason! I bet you never buy and will not buy if even SP rolls to 142P by saying that Right issue is imminent and wait for a £ Mark and so on. Anyway you enjoy IAG SP to fall further and good luck to you.

There is no need to be sentimental and use abusive language! You should criticise at Fum board who may be responsible for decline in SP since MED 3000 approval in Europe by failing to introduce their innovative product at least in Europe.
Let us hope soon they introduce by some form like online product and then we know the outcome ! It is simple is that!
Agreeing on some points with Liam , it doesn’t mean to harm the fum.

No worries, I have written a email and you write as well and it will be interesting to see to see what they say!

You should blame Fum team for the decline in SP because they are unable to introduce the product in Europe after its approval. All we are making the Fum directors aware that please do something to introduce the product in Europe at least to halt the decline in SP.

Please note I am not that so lucky to work for any Big Pharma and I am simply a investor. I am sorry to agree with Liam because there is some element of some truth in it.
Can any body tell that what Fum have done after the approval of MED 3000 in Europe to introduce the product in Europe. I will be very happy and wishing every success to Fum to recoup my losses but they don’t seem to be doing anything to manufacture and market the product in Europe. There is nothing wrong they should try to introduce the product on line because they are unable to attract partner in Europe to manufacture and market the product.

Agreed Ammu123: In case of any Spike in COVID leading to more restrictions, Boohoo will do well because of tendency of people to order on line

LB: you are absolutely correct : Marketing is not a joke and it needs lot of expertise and funds and this is the reason you will need a big Pharma to come along to collaborate!
And in the absence of it it is a monumental task to introduce the product. It is ironical that Fum directors have not done anything to introduce the product in Europe since MED 3000 approval 6 months ago. In the absence of any large Pharma , at least they would have set a website to introduce MED 3000 by contracting 3rd party manufacturer to produce MED 3000. In my view there is a very remote hope of any success of MED 3000 because very dismal record of FUM.

Prae:Very good advice and sit tight if you are in loss and sell to have some profit of course if you like and buy cheaper later on!

True up to certain degree! But these parameters are not in your control!
Just saw the headlines and it is scary really!

UK's Covid cases spike by another 15% in a week to brink of 50,000 while hospitalisations and deaths continue to jump as Sajid Javid gets set for first 5pm press conference in a month TONIGHT as fears grow over new Delta variant and NHS demands 'PLAN C'

Let us hope COVID situation doesn’t go out of hand which is the main worry to drive SP to crash because travelling will be limiting?

PetitStVincent: if Eroxon is successful, then it will be good for Eroxon and not for fum because they have no idea to take advantage of the situation: Fum have enough funds and at least they would have tried to sell MED3000 on line by setting up website and manufacturing the product by contracting third party. Fum teams are sleeping giants and will eat the funds until it goes into administrations.

Fugazi1: you are on full throttle and keep your funds ready, I mean virtual funds and it may reach 142 P much sooner than you think.

I am not surprised BB. The stock has had good run since from middle of Sept from 137 P around to 190P. You should not fall in love with stock and try to make some profit and move on or cut your losses ?

sundezena: you are absolutely correct because Fugazi! has a wild dream and he is dreaming all the time!

Fugazi1: Keep your funds ready because you have been dreaming for 142 P for a while!

Agreed iparsnip: although patents are first steps and they don’t have any significance until the final product is manufactured but this is very very long shot. Unless very large pharmaceutical company involves Nuvec will be stuck to research desks

You are right Mozart: let us hope sooner or later any large Pharma gets on board to develop and implement Nuvec sooner than later because other ideas may take over the market

Agreed Mr Triumph, I think Nuvec is good concept but it is very long shot and unless any large Pharma becomes partner to speed up the process to its product development and delivery ,Nuvec will be sitting idle up to patent approvals and research extent and other companies will take the market by developing their ideas and products .

No idea, if it is fantastic news for N4P

BBC News:
An experimental drug for severe Covid cuts the risk of hospitalisation or death by about half, interim clinical trial results suggest.
The tablet - molnupiravir - was given twice a day to patients recently diagnosed with the disease.
US drug-maker Merck said its results were so positive that outside monitors had asked to stop the trial early.
It said it would apply for emergency use authorisation for the drug in the US in the next two weeks.